Montreal-based THORASYS Thoracic Medical Systems Inc., which applies cutting-edge research to develop respiratory medical devices, has raised $360K in new funding. The company specializes in designing and manufacturing pulmonary function test equipment for diagnosing and monitoring lung diseases such as Asthma and COPD.
Its flagship product, the tremoFlo™ C-2 Airwave Oscillometry System (AOS) ™, is a compact and portable device that provides an effortless assessment of lung function. THORASYS has already seen significant interest from leading research and medical institutions for its innovative technology.
